Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,785,701
in 13 filings, $4.6M under 10b5-1 plans

Net −$5,785,701. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Coloma Jason V −$3.5M Chief Executive Officer sold 40% of stake
  2. Bernstein Harold −$1.4M President, R&D & CMO sold 100% of stake
  3. Dandekar Atul −$819K CSBO sold 47% of stake
  4. Courtney Phillips −$105K GC and Corp. Secretary sold 36% of stake
Date Insider Transaction Shares Price Value Owned after
2025-02-03 Lim Jonathan E Director Conversion +37,724 37,724
2025-02-03 Lim Jonathan E Director Conversion +270,232 307,956
2025-02-03 Lim Jonathan E Director Conversion · Series A Preferred Stock −363,703 0
2025-02-03 Lim Jonathan E Director Conversion · Series B Preferred Stock −2,231,381 0
2025-02-03 HOMCY CHARLES J Director Conversion +8,807 37,330
2025-02-03 HOMCY CHARLES J Director Conversion +20,717 58,047
2025-02-03 HOMCY CHARLES J Director Conversion +7,422 7,422
2025-02-03 HOMCY CHARLES J Director Conversion · Series B Preferred Stock −72,727 0
2025-02-03 HOMCY CHARLES J Director Conversion · Series C Preferred Stock −169,405 0
2025-02-03 HOMCY CHARLES J Director Conversion · Series D-1 Preferred Stock −71,564 0
2025-02-03 Third Rock Ventures IV, L.P. 10% owner Conversion +5,762,788 6,073,958
2025-02-03 Third Rock Ventures IV, L.P. 10% owner Conversion +950,800 950,800
2025-02-03 Third Rock Ventures IV, L.P. 10% owner Conversion · Series A Preferred Stock −45,833,334 0
2025-02-03 Third Rock Ventures IV, L.P. 10% owner Conversion · Series D-1 Preferred Stock −9,725,709 0
2025-02-03 Third Rock Ventures IV, L.P. 10% owner Conversion · Series A Preferred Stock −9,166,666 0
2024-12-09 Lim Jonathan E Director Grant or award · Stock Option (Right to Buy) +5,704 5,704
2024-12-09 Lim Jonathan E Director Returned to the company · Stock Option (Right to Buy) −5,704 0
2024-12-09 Lim Jonathan E Director Grant or award · Stock Option (Right to Buy) +9,086 9,086
2024-12-09 HOMCY CHARLES J Director Grant or award · Stock Option (Right to Buy) +80,385 80,385
2024-12-09 HOMCY CHARLES J Director Returned to the company · Stock Option (Right to Buy) −80,385 0

Page 13 of 14 · 267 trades